Modalis Therapeutics Corporation

4883 TSE Pharmaceuticals Pharmaceutical
TSE Growth
¥36.00
-16.28%
Delayed · cached 15 min

Fair value analysis

Reported earnings per share are negative or zero, so the earnings-based models cannot produce a value.

Financial DNA score 19 / 100

Educational data only. Not a recommendation to buy, sell or hold any security.

Educational data only. Not a recommendation to buy, sell or hold any security.